Addresses
Background High levels of homocysteine and oxidative stress are known to be associated with premature vascular disease in type 2 diabetes mellitus (DM). The aim of this study was to estimate homocysteine levels and oxidant-antioxidant status and to determine the relationship between them in type 2 diabetic patients with and without microalbuminuria.
Methods Fasting blood samples were obtained from 48 diabetic patients (17 with and 31 without microalbuminuria) and 20 healthy subjects. Serum total homocysteine (tHcy), plasma malondialdehyde (MDA) erythrocyte glutathione (GSH) and glutathione peroxidase (GPx) activity were measured in these patients and the results were compared with those of controls who were chosen among healthy subjects.
Results MDA levels were found to be significantly lower and GSH levels and GPx activities were found to be significantly higher in control subjects when compared with patients with and without microalbuminuria (MDA: Po0.0001, Po0.0001; GSH: Po0.0001, Po0.0001; GPx: Po0.0001, Po0.001, respectively). MDA levels were found to be significantly higher in patients with microalbuminuria compared with patients without microalbuminuria (Po0.0001), while similarly GSH levels were found to be significantly lower in patients with microalbuminuria (Po0.0001). Although there were no significant differences with respect to tHcy levels and GPx activities between the microalbuminuric and normoalbuminuric patients (P40.05), there was a significant difference with respect to tHcy levels between healthy controls and patients with microalbuminuria (Po0.05). The serum levels of tHcy correlated best with plasma MDA and erythrocyte GSH concentrations in all diabetic patients (r ¼ 0.549, Po0.0001; r ¼ À0.385, Po0.01).
Introduction
Type 2 diabetes mellitus (DM) is well known to be associated with an increased risk of all-cause and cardiovascular mortality. Lipid peroxidation of cellular polyunsaturated hydrocarbons is believed to be caused by endogenously generated toxic oxygen reduction metabolites and a considerable amount of research has been reported of studies on ageing, atherosclerosis and the complications of DM. Free radical reactions may play an important role in diabetic complications. 1 DM has been shown to result in increased free radical formation. 2 The most important free radicals that cause oxidative stress are superoxide (O À 2 ), hydroxyl radical ( OH) and hydrogen peroxide (H 2 O 2 ). In human erythrocytes there are antioxidant enzymes together with cytoplasmic radical scavengers directed against free radicals in order to protect erythrocytes. 3 One of the cytoplasmic radical scavengers that can reduce free radicals is reduced glutathione (GSH). Glutathione peroxidase (GPx) catalyses the reduction of peroxide. It is generally believed that the protective e¡ect of GSH against the oxidative breakdown of lipids is mediated through GPx by the reduction of endogenously formed hydroperoxides of unsaturated fatty acids to hydroxyl derivatives. 4 Although the pathogenic mechanism of vascular complications in type 2 DM is very complex, free radical reactions induced by reactive oxygen species are thought to be one of the possible factors involved. 5 The increased risk of cardiovascular disease in individuals with microalbuminuria is only partly due to a higher prevalence of established risk factors such as DM. The pathophysiological basis of the association between microalbuminuria and underlying generalized vascular injury may be endothelial dysfunction. 6 High plasma or serum total homocysteine (tHcy) concentration is a risk factor for atherothrombotic diseases 7 which has recently come under increased scrutiny. 8 A recent prospective study showed that the plasma tHcy concentration was a signi¢cant predictor of six-year all-cause mortality risk, both in patients with normoalbuminuria and those with microalbuminuria. 9 It is possible that alterations in free radical activity and hyperhomocysteinaemia may be important in the pathogenesis and high prevalence of cardiovascular disease in microalbuminuric type 2 DM. 2, 10 There has been no previous detailed study relating the plasma lipid peroxidation (i.e. malondialdehyde [MDA] production) and homocysteine in type 2 DM with and without microalbuminuria.
In view of these considerations, we determined the plasma MDA, GSH, GPx and tHcy levels, and examined the relationship between these parameters in type 2 DM patients with and without microalbuminuria.
Patients and methods
In all, 48 type 2 DM patients (24 women, 24 men; age range 30--70 years) and 20 control subjects (10 women, 10 men; age range 34--75 years) were studied. Patients with hypertension were excluded and therefore no patient within the study received antihypertensive agents. The diagnosis of type 2 DM was established according to the Report of the Expert Committee on Diagnosis and Classi¢cation of Diabetes Mellitus. 11 The patients did not have episodes of ketoacidosis, ketonuria or overt proteinuria.
Urine albumin was measured in 24-h urine collections by turbidimetric immunoassay using the Sigma microalbumin diagnostic kit (Sigma-Aldrich, Deisenhofen, Germany) on a Beckman CX-9 ALX autoanalyzer (Beckman Coultes Inc, Fullerton, CA, USA); urinary albumin excretion (UAE) was expressed in milligrams per 24 h. The patients were divided into two subgroups according to UAE: (a) normoalbuminuric with UAE less than 30 mg/24 h (n ¼ 31) and (b) microalbuminuric with UAE from 30 to 300 mg/24 h (n ¼17). Non-diabetic control subjects were recruited from among the clinical and laboratory sta¡ and their families, and were selected to match for age and gender distribution of the diabetic group as a whole. None of the control subjects had a history of cardiovascular disease. Subjects characteristics are given in Table1. It can be seen from the signi¢cant statistical di¡erences under the table that there is incompleteness in the matching of the patients.
Two tubes of blood (whole blood for serum and disodium EDTA anticoagulated blood) were taken from the antecubital veins of each patient. In all, 200 mL of anticoagulated blood was taken for GSH measurement and the remaining blood samples (whole blood and anticoagulated blood) were centrifuged at 3000 rotations per miute (rpm) for 10 min at 41C to obtain serum and plasma. After removal of the plasma, the remaining erythrocyte mass was washed thrice with 0.9% NaCl solution and chilled to 41C. Erythrocytes for GPx analysis were haemolysed by the addition of an equal volume of deionized water.
Serum glucose, triglycerides, total cholesterol, HDL-cholesterol and creatinine concentrations were determined with Technicon kits (Technicon, Bayer Diagnostics, New York, USA) on a Beckman CX-9 ALX autoanalyzer. The estimation of serum tHcy was carried out using the IMX analyzer (Abbott Diagnostics, Chicago, USA). The method measures the total concentration of thiol-, disulphide-, mixed disulphide-and protein-bound forms of homocysteine in the sample. Haemoglobin and haematocrit concentrations were estimated in the haemolysate using commercial reagent on Cell Dyn 3500 analyzer (Abbott diagnostics, Chicago, USA). Glycosylated haemoglobin (HbA 1C ) was determined with the AXSYM System (Abbott Diagnostics, Chicago, USA). Plasma lipid peroxide concentration, expressed in terms of MDA, was determined by the thiobarbituric acid method. 12 Erythrocyte GPx activity was measured by the method of Paglia and Valentine 13 and is expressed as MU/mol Hb. GSH concentration was assayed using the method of Beutler et al. 14 and expressed as mmol/L of red blood cells (RBCs).
The study was approved by the Ethics Commitee of the Medical Faculty of the Kocaeli University.
All data are expressed as the mean7standard deviation (SD) and median. Data were analysed using the Kruskall--Wallis and Mann--Whitney U test. Normoalbuminuric and microalbuminuric groups were compared using Wilcoxon's test. Pearson's correlation test was used to determine the correlation of tHcy with MDA, GSH and GPx. Di¡erences were considered sig-ni¢cant at the level of Po0.05.
Results
MDA levels were found to be signi¢cantly lower in control subjects (0.0770.02 mmol/L) when compared with patients with (0.1370.02 mmol/L) and without (0.0970.01mmol/L) microalbuminuria (Po0.0001 and 0.0001, respectively; see Table 2 ). On the other hand, GSH levels and GPx activities were found to be signi¢cantly higher in control subjects (2.170.49 mmol/L RBCs and 3.1172.49 MU/mol Hb) when compared with patients with (0.6470.14 mmol/L RBCs and 0.6870.08 MU/mol Hb) and without (0.9970.26 mmol/L RBCs and 0.7970.29 MU/mol Hb) microalbuminuria (Po0.0001, 0.0001; Po0.0001, 0.001, respectively; see Table 2 ). MDA levels were found to be signi¢cantly higher in patients with microalbuminuria when compared to patients without microalbuminuria (Po0.0001), while similarly GSH levels were found to be signi¢cantly lower in patients with microalbuminuria (Po0.0001). Although there were no signi¢cant di¡erences with respect to tHcy levels and GPx activities between the microalbuminuric and normoalbuminuric patients (P40.05), there was signi¢cant di¡erence with respect to tHcy levels between healthy controls (9.571.9 mmol/L) and patients with microalbuminuria (Po0.05; see Table. 2). The serum levels of tHcy correlated best with plasma MDA, and erythrocyte GSH concentrations in all diabetic patients (r ¼ 0.549, Po0.0001; r ¼ À0.385, Po0.01; Figure 1. ).
Discussion
The signi¢cant increase in MDA and decrease in GSH and GPx levels of patients with type 2 DM compared with the control group suggests permanent structural membrane alterations in diabetes, as well as increased production of reactive oxygen species and decreased antioxidants in the circulation. 15--17 It has been proposed that a diabetics' blood is more prone to lipid peroxidation due to the impaired antioxidant defence system. 17, 18 In fact, oxidative stress is an imbalance between free radical production and lipid peroxidation on one hand, and the antioxidant defence system on another. The pro-oxidant--antioxidant imbalance in diabetes may be due to either acceleration of cellular reactions leading to increased free radical production, such as non-enzymatic protein glycation, glucose oxidation and increased sorbitol pathway, or reduced antioxidant defence potential. 19, 20 This study provides evidence that the imbalanced MDA and GSH levels are more pronounced in type 2 DM patients with microalbuminuria. Plasma MDA levels correlate with the duration of type 2 DM. 17 Excessive lipid peroxidation in the plasma can arise due to factors favouring the formation of reactive oxygen species. In poorly controlled DM, glucose oxidation through the pentose phosphate pathway leads to excessive formation of NADPH, which in turn can promote lipid peroxidation in the presence of the cytochrome P-450 system. 21 Oxyhaemoglobin in erythrocytes could act like cytochrome P-450 in the presence of NADPH and this could induce increased lipid peroxidation. 22 Furthermore, inactivation or inhibition of antioxidant enzymes by glycosylation in poorly controlled DM may give rise to increased lipid peroxidation. 17 Free radical reactions cause the oxidation and peroxidation of membrane lipids, denaturation of proteins, disturbed membrane permeability and increased in£ammatory cell in¢ltration. 23 In addition, it is suggested that the increase in free radical activity demonstrated in diabetes coexists with a reduction in the antioxidant state, 24 and could therefore potentially increase the deleterious e¡ects of free radicals.
Microalbuminuria is a strong predictor of cardiovascular morbidity and mortality in type 2 DM. 25 The increased risk of cardiovascular disease in individuals with microalbuminuria is only partly due to a higher prevalence of established risk factors such as diabetes, hypertension, smoking and dyslipidaemia. Hyperhomocysteinaemia is another recently recognized risk factor for cardiovascular disease. 26 The present study shows that there is signi¢cant increase in homocysteine levels in type 2 DM patients with microalbuminuria compared with control patients. Microalbuminuria is thought to be caused by increased glomerular albumin ¢ltration as a result of decreased glomerular charge selectivity and increased intraglomerular pressure, 27 regulation of which is a¡ected by renal endothelial and mesangial cell function. 28 Mesangial cells have some properties in common with vascular smooth muscle cells. 27 Hyperhomocysteinaemia may induce dysfunction of the vascular endothelium 29 and increase proliferation of vascular smooth muscle cells, 30 possibly by increasing oxidative stress. 31 The present study supports that hyperhomocysteinaemia is signi¢cantly related to increasing oxidative stress and decreasing GSH. For type 2 DM patients there was also signi¢cant positive correlation between MDA and homocysteine and a negative correlation between GSH and homocysteine levels. Increased homocysteine levels result in increased risk of atherosclerosis. 9 Increased MDA levels are due to increased free radical production. Both homocysteine and free radicals oxidize LDL, which results in endothelial damage increasing the risk of atherosclerosis. 2 Thus, increased levels of homocysteine and MDA are associated with increased risk of atherosclerosis.
In conclusion, decreased antioxidant levels and increased lipid peroxidation and homocysteine levels were observed in patients with microalbuminuria. These changes may contribute to vascular disease, which is particularly prevalent in type 2 DM patients with microalbuminuria.
